India provides advanced, cost-effective treatment for intraocular melanoma through top ocular oncology centers and globally experienced oncologists like Dr. Ankur Bahl. Treatment in India typically ranges between $4,500 and $9,000, depending on complexity. In contrast, costs may exceed $35,000–$60,000 in the USA and $18,000–$28,000 in Thailand. India offers excellent outcomes at significantly lower prices, with world-class care.
Intraocular melanoma is a rare cancer that originates in the melanocytes within the eye. These are pigment-producing cells found in various parts of the eye, primarily in the uvea (which includes the choroid, ciliary body, and iris). This form of cancer is most common in adults and often arises silently, detected during routine eye exams.
Though rare, intraocular melanoma can be life-threatening if not caught early. It may metastasize, particularly to the liver. Early detection and a multidisciplinary approach are essential for preserving vision and life.
The main types include:
These are further categorized by size and metastatic risk (small, medium, large tumors).
India uses advanced diagnostic tools for accurate assessment:
Initial Evaluation and Imaging – Full ocular and systemic workup
Treatment Plan Selection – Based on tumor size, vision status, and spread
Treatment Modalities:
a. Plaque Brachytherapy
– Radioactive plaque placed on eye for a few days
– Preserves vision in many cases
b. Proton Beam Therapy
– Precision radiation, used in select centers
c. Enucleation
– Complete removal of the eye for large/invasive tumors
d. Transscleral Resection or Endoresection
– Eye-sparing surgeries for selected tumors
e. Systemic Therapy
– For metastasis: Immunotherapy (nivolumab), targeted therapy (trametinib, MEK inhibitors)
f. Follow-Up Care
– Vision rehabilitation, prosthetic fitting if enucleation is done
Dr. Ankur Bahl is a leading oncologist in India with:
Treatment Component |
Estimated Cost (USD) |
Consultation & Diagnostics |
$300 – $500 |
Ocular Imaging & Biopsy |
$500 – $800 |
Radiation (Plaque/Proton) |
$1,500 – $3,000 |
Surgery (Enucleation/Laser) |
$1,800 – $3,500 |
Medications & Follow-Up |
$300 – $700 |
Total Estimated Cost |
$4,500 – $9,000 |
Country |
Estimated Total Cost |
India |
$4,500 – $9,000 |
Thailand |
$18,000 – $28,000 |
USA |
$35,000 – $60,000 |
Patients can save up to 80% in India while receiving equivalent or superior care.
Case-based evaluation ensures personalized treatment.
Intraocular melanoma, though rare, is highly treatable—especially with early detection and proper care. India has emerged as a global destination for affordable, high-quality cancer treatment, including rare eye cancers. With leading specialists like Dr. Ankur Bahl, access to advanced therapies, and full international support, India offers a powerful combination of expertise, affordability, and compassionate care. Whether you're seeking a second opinion or comprehensive treatment, India stands ready to support your journey to recovery.
Yes, especially if detected early. Small tumors treated with radiation or surgery often have excellent outcomes. Life expectancy is high with localized disease.
Not necessarily. Treatments like plaque therapy aim to preserve vision. Enucleation is done only when absolutely necessary, and prosthetics are available.
No. It is only recommended for large or deeply invasive tumors. Many cases can be managed conservatively with radiation or local resection.
Yes. Many top hospitals in India are JCI- and NABH-accredited, following international safety and quality protocols.
Yes, many hospitals accept international insurance or provide documentation for reimbursement. Check with your provider for eligibility.
Most patients stay for 3–5 days post-surgery. For plaque therapy, a 2–3 day admission is typical. Pre/post-hospital stays depend on your recovery.
Absolutely. Indian hospitals offer virtual follow-ups, review of test reports, and guidance through secure platforms.